Kalajaji: Benefits, Evidence, Dosage & Safety
TL;DR
Kalajaji is black cumin (Nigella sativa) seed, an Ayurvedic spice-medicine. Meta-analyses of RCTs find modest drops in blood pressure (~3 mmHg) and improvements in fasting glucose and HbA1c; a 4-trial meta-analysis found better asthma control. Effects are small and trials short: it is an adjunct, not a replacement for prescribed treatment.
(55 words. Sources: Sahebkar et al. 2016, meta-analysis; Daryabeygi-Khotbehsara et al. 2022, meta-analysis; Han et al. 2021, meta-analysis.)
What it is
Kalajaji is the seed of Nigella sativa L. (family Ranunculaceae), an annual flowering plant whose trigonous black seeds are used as both spice and medicine (API monograph mirror). The Ayurvedic Pharmacopoeia of India lists the drug as "Upakunchika," defined as the seeds of Nigella sativa Linn., with Sanskrit synonyms including Sthalajiraka. "Kalajaji" is the accepted Sanskrit vernacular name per the NCISM syllabus material (same API source; NCISM syllabus deck). It is widely known as kalonji or black cumin in Hindi and black seed in English. The seeds and the cold-pressed seed oil are the parts used; the seed's best-studied bioactive compound is thymoquinone (PMC review).
Traditional use
Classical Ayurvedic sources describe kalajaji (as upakunchika) as deepana and pachana, stimulating appetite and digestion, and attribute grahi (absorptive), medhya (mind-supporting), and fever-alleviating properties to it in the Bhavaprakasha Nighantu tradition (NCISM syllabus deck). These are traditional claims, not clinical proof: the trial evidence is assessed separately below.
What modern research says
Blood pressure
In a 2016 systematic review and meta-analysis of 11 RCTs (860 participants), N. sativa powder reduced systolic blood pressure by about 3.3 mmHg and diastolic by about 2.8 mmHg versus control over roughly 8 weeks. The effect was seen with seed powder rather than oil (Sahebkar et al., Journal of Hypertension). An updated 2023 meta-analysis of RCTs found a similar small reduction: about −3.1 mmHg systolic and −2.7 mmHg diastolic (PubMed). This is a modest, adjunctive effect: not a substitute for antihypertensive treatment.
Blood sugar and metabolic markers
A 2022 systematic review and meta-analysis of 11 RCTs in people with prediabetes or type 2 diabetes found that N. sativa supplementation significantly improved fasting plasma glucose, HbA1c, total cholesterol, and LDL cholesterol, with greater effects at doses above 1 g/day and durations beyond 8 weeks (Daryabeygi-Khotbehsara et al., Frontiers in Nutrition). A 2024 updated meta-analysis of 30 RCTs likewise found significant reductions in fasting blood sugar and HbA1c, but noted very high heterogeneity between trials and called for better-designed, longer studies to establish ideal dosing (PubMed). The signal is consistent but the trials are small and varied.
Asthma and breathing
A 2021 meta-analysis of 4 RCTs (187 patients) found that N. sativa supplementation improved asthma control scores and FEV1 versus control (Han et al., Postępy Dermatologii i Alergologii). In a single-blind RCT, 1–2 g/day of seed for 12 weeks improved asthma control test scores, reduced exhaled nitric oxide, and increased FEV1 (Salem et al., 2017, via review). Separately, an experimental study in 15 asthmatic patients found the boiled extract had a measurable bronchodilatory effect, though weaker than theophylline (Boskabady et al., Phytomedicine). Evidence is promising but limited to small trials.
What the evidence does not support (yet)
Laboratory studies report anti-cancer effects of thymoquinone in cell and animal models, but there are no human trials establishing any anti-cancer effect of N. sativa: cell-culture findings are not clinical evidence (PMC review). Claims that black seed "cures" a long list of diseases go well beyond the data.
Dosage
There is no officially established dose, but clinical trials provide reference ranges. RCTs have used 1–3 g/day of seed powder (a 94-patient trial found 2 g/day effective for glycemic control over 12 weeks) or about 1 g/day of seed oil (500 mg capsules twice daily for 4 weeks in an asthma trial), typically for 4–12 weeks (Bamosa et al., 2010, PMID 21675032, via meta-analysis; Salem et al., 2017; Koshak et al., 2017, via review). Meta-analyses suggest effects are more consistent above 1 g/day and beyond 8 weeks (Daryabeygi-Khotbehsara et al.). These are trial doses, not recommendations: discuss use with a clinician.
Safety & contraindications
Short-term trials generally reported mild or no adverse effects (Hosseini et al., 70-patient RCT, via summary; Koshak et al., 2017, via review). Avoid medicinal doses in pregnancy: animal studies report that high-dose N. sativa extracts prevented pregnancy in rats and that high-dose thymoquinone disrupted embryonic development, so therapeutic doses are not advised during pregnancy (review of reproductive-toxicity studies). Because trials show it can lower blood pressure and blood sugar, it may add to the effects of antihypertensive and antidiabetic medicines: monitor and talk to your doctor if you take them (Sahebkar et al.; Daryabeygi-Khotbehsara et al.).
FAQs
Is kalajaji the same as kalonji?
Yes. Kalajaji is the Sanskrit name for the seeds of Nigella sativa, sold and cooked as kalonji (Hindi), black cumin, or black seed. The Ayurvedic Pharmacopoeia of India lists the same drug as "Upakunchika": seeds of Nigella sativa Linn.: confirming the identity across names (API monograph).
Does kalajaji lower blood pressure?
Modestly. Two meta-analyses of RCTs found N. sativa reduced systolic pressure by about 3 mmHg and diastolic by about 2.7–2.8 mmHg over roughly two months, with the effect seen mainly for seed powder (Sahebkar et al.; 2023 update). That is a small adjunctive effect, not a replacement for prescribed blood-pressure treatment.
Does kalajaji help with diabetes?
Possibly, as an adjunct. A 2022 meta-analysis of 11 RCTs in prediabetes and type 2 diabetes found significant improvements in fasting glucose and HbA1c, and a 2024 meta-analysis of 30 RCTs agreed, though with high between-trial variability (Frontiers meta-analysis; PubMed). It should never replace diabetes medication: discuss it with your doctor.
Does kalajaji help asthma?
Early evidence is encouraging but thin. A meta-analysis of 4 small RCTs found improved asthma control scores and lung function, and one 12-week trial of 1–2 g/day improved airway-inflammation markers (Han et al.; Salem et al., 2017). This is not a substitute for inhalers or prescribed asthma care.
Is kalajaji safe in pregnancy?
Medicinal doses are best avoided in pregnancy. Animal studies found high-dose N. sativa extracts interfered with pregnancy in rats and high-dose thymoquinone disrupted embryo development (reproductive-toxicity review). Ordinary culinary amounts as a spice are a different matter, but supplements should wait until after pregnancy and breastfeeding: talk to your clinician.
How is kalajaji usually taken?
In trials, 1–3 g/day of ground seed powder or about 1 g/day of seed oil was used for 4–12 weeks (Daryabeygi-Khotbehsara et al.). Traditionally the seeds are taken as powder with honey or warm water, or used as a cooking spice. Start low, watch blood pressure and blood sugar if you take related medicines, and get clinician guidance.
Sources
- Ayurvedic Pharmacopoeia of India — "Upakunchika" monograph (seeds of Nigella sativa Linn.): yumpu.com
- NCISM syllabus deck — Upakunchika (Kalajaji): vernacular names and classical properties: slideshare.net
- Ahmad A et al. "A review of therapeutic potential of Nigella sativa." PMC — PMC · PMC5633668
- Sahebkar A et al. "A systematic review and meta-analysis of randomized controlled trials investigating the effects of supplementation with Nigella sativa (black seed) on blood pressure." J Hypertens. 2016 — PubMed · PMID 27512971
- "Antihypertensive effects of Nigella sativa supplementation: An updated systematic review and meta-analysis." Phytother Res. 2023 — PubMed · PMID 37341696
- Daryabeygi-Khotbehsara R et al. "*Nigella sativa* supplementation improves cardiometabolic indicators in population with prediabetes and type 2 diabetes mellitus." Front Nutr. 2022 — PMC · PMC9403837
- "The effect of Nigella sativa supplementation on glycemic status in adults: An updated systematic review and meta-analysis." 2024 — PubMed · PMID 39181437
- Han A et al. "The efficacy of Nigella sativa supplementation for asthma control: a meta-analysis of randomized controlled studies." 2021 — PMC · PMC8501420
- "Clinical and experimental effects of Nigella sativa and its constituents on respiratory and allergic disorders." PMC (covers Salem 2017, Koshak 2017) — PMC · PMC6526035
- Boskabady MH et al. "Antiasthmatic effect of Nigella sativa in airways of asthmatic patients." Phytomedicine. 2010 — PubMed · PMID 20149611
- "Safety evaluation of Phytovagex, a pessary formulation of Nigella sativa, on pregnant rats." PMC (reviews reproductive-toxicity studies) — PMC · PMC4884224
Related herbs
Disclaimer
This article is for educational purposes only and is not medical advice. Herbal products can interact with medications and are not suitable for everyone. Talk to a qualified healthcare practitioner before use — especially if you are pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.